Ezetimibe
Who holds supplier records for Ezetimibe? 21 organisations hold a current record for Ezetimibe: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (16), China (3) and Netherlands (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Ezetimibe: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ezetimibe
Reading the evidence
- 21 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
16 of the 20 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 12 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Ezetimibe expires 30 Apr 2026. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (21)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Ezetimibe. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ALIVUS LIFE SCIENCES LTDIndia Company GMP cert on recordActive DMF 24825, 19717, 27303 · latest filing Sept 2013
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 26972, 21554, 29132 · latest filing Mar 2015
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 30801, 37368 · latest filing Jul 2022
- CHANGZHOU PHARMACEUTICAL FACTORYChina Company GMP cert on recordActive DMF 35963, 24511 · latest filing May 2021
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 39275, 27896 · latest filing Dec 2023
- Hetero Labs LimitedIndia Company GMP cert on recordActive DMF 29882, 29158 · latest filing Oct 2015
- Lupin LimitedIndia Company GMP cert on recordActive DMF 28173, 23541, 30378 · latest filing Apr 2016
- TAPI NL BVNetherlandsActive DMF 26068, 20039 · latest filing May 2012
- Viyash Scientific LtdIndia Company GMP cert on recordActive DMF 43367, 39339 · latest filing Jan 2026
- Alkem Laboratories LimitedIndia Company GMP cert on recordActive DMF 39934 · latest filing May 2024
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 30981 · latest filing Nov 2016
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 25653 · latest filing Dec 2011
- MICRO LABS LTDIndia Company GMP cert on recordActive DMF 37728 · latest filing Dec 2022
- Neuland Laboratories LimitedIndiaActive DMF 22573, 25543 · latest filing Nov 2011
- RAKS PHARMA PVT LTDIndiaActive DMF 31082 · latest filing Dec 2016
- SAPTAGIR LABORATORIES PRIVATE LTDIndiaActive DMF 37522 · latest filing Sept 2022
- SHOBHA LIFE SCIENCES PRIVATE LIMITEDIndiaActive DMF 41914 · latest filing Jun 2025
- SYNTHIMED LABS PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 40885 · latest filing Jan 2025
- WUHAN ZY PHARMACEUTICAL CO LTDActive DMF 29622 · latest filing Jul 2015
- Zhejiang Jingsheng Pharmaceutical Co., Ltd.ChinaActive DMF 39410 · latest filing Jan 2024
- Zhejiang Tianyu Pharmaceutical Co., Ltd.ChinaActive DMF 32716 · latest filing Sept 2021
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (2)
Organisations whose Type II DMFs for Ezetimibe are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- China · Inactive DMF 28942 · filed Dec 2014
- SIGNA SA DE CVInactive DMF 26637 · filed Dec 2012
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (12 listed products contain Ezetimibe). The latest listed patent expires 30 Apr 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Ezetimibe is used to reduce the amount of cholesterol and related sterols absorbed in the small intestine, which helps lower blood cholesterol levels. It is often combined with statins to further reduce cholesterol levels in hyperlipidemic patients.
Chemical identity
- IUPAC name
- (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one
- Canonical SMILES
- C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O
- InChIKey
- OLNTVTPDXPETLC-DLTGEIKXSA-N
- Synonyms
- Zetia API
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Dietary Cholesterol Absorption Inhibitor
- Physiologic effect
- Decreased Cholesterol Absorption
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Ezetimibe?
21 organisations hold an active US FDA Type II Drug Master File or a CEP for Ezetimibe: ALIVUS LIFE SCIENCES LTD (India), MSN Laboratories Private Limited (India), APITORIA PHARMA PRIVATE LTD (India), CHANGZHOU PHARMACEUTICAL FACTORY (China), Dr. Reddy's Laboratories Ltd. (India), Hetero Labs Limited (India), Lupin Limited (India) and TAPI NL BV (Netherlands), and 13 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Ezetimibe Drug Master Files are active?
ALIVUS LIFE SCIENCES LTD (DMF 24825, 19717), MSN Laboratories Private Limited (DMF 26972, 21554), APITORIA PHARMA PRIVATE LTD (DMF 30801, 37368), CHANGZHOU PHARMACEUTICAL FACTORY (DMF 35963, 24511), Dr. Reddy's Laboratories Ltd. (DMF 39275, 27896), Hetero Labs Limited (DMF 29882, 29158), Lupin Limited (DMF 28173, 23541) and TAPI NL BV (DMF 26068, 20039) and 13 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Ezetimibe records mean?
2 organisations have only inactive Type II DMFs for Ezetimibe. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does the FDA Orange Book list patents for products containing Ezetimibe?
Yes. The latest patent listed for an approved US product containing Ezetimibe expires 30 Apr 2026, across 12 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Ezetimibe supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Ezetimibe?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.